glp 1 medications for obesity GLP-1 Medications: Everything You Need to Know How GLP-1 medications are transforming

A June 2024 Lilly study demonstrated that tirzepatide (brand names Monjauro and Zepbound) was superior to a placebo in improving fibrosis with 190 patients over 52 weeks

10.02.25 Pending actions increased leading into October With the addition of more than 100 cases in September, there were 2,809 pending actions in the GLP-1 MDL as of October 1

Subsequently, the AGA released a rapid clinical practice update advising an individualized approach prior to endoscopy, based on GLP-1RA indication, presence of symptoms, duration of fasting, and whether the endoscopy was required urgently [22]

Gastrointestinal side effects may worsen temporarily after the dose increase but typically stabilize within a week

Compounded semaglutide injection ($149/mo starting) is ideal for thyroid patients because it bypasses the stomach entirely, eliminating absorption conflicts with levothyroxine